Companies / Financials
MS
Morgan Stanley
Investment Banking & Brokerage
Investment Banking & BrokerageAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health81
Growth65
Profitability96
Cash generationn/a
Balance sheetn/a
Dilution control81
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)11.6%Revenue growth (FY)14.4%Revenue CAGR (3y)9.6%Gross margin—Operating margin—Net margin23.9%Free cash flow margin-25.3%R&D / revenue—Stock comp / revenue2.7%Net debt / operating cash flow—Current ratio—Diluted share count change-1.2%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $59.8B | $53.7B | $54.1B | $61.8B | $70.6B |
| Net income | $15.0B | $11.0B | $9.1B | $13.4B | $16.9B |
| Operating cash flow | $34.0B | -$6.4B | -$33.5B | $1.4B | -$17.9B |
| Free cash flow | $34.0B | -$6.4B | -$33.5B | $1.4B | -$17.9B |
| Stock-based comp | $2.1B | $1.9B | $1.7B | $1.6B | $1.9B |
| Dividends | $4.2B | $5.4B | $5.8B | $6.1B | $6.6B |
| Cash | $127.7B | $128.1B | $89.2B | $105.4B | $111.7B |
| Total debt | $227.4B | $233.9B | $260.5B | $284.3B | $341.7B |
| Equity | $105.4B | $100.1B | $99.0B | $104.5B | $111.6B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.